Showing results (1-10 of 10) with videos related to
Sort By:
Pageof 1
European Journal of Medicinal Chemistry|January 7, 2017
Synthesis and biological evaluation of deferiprone-resveratrol hybrids as antioxidants, Aβ1-42 aggregation inhibitors and metal-chelating agents for Alzheimer's diseasePing Xu, Minkui Zhang, Rong Sheng, et al.Bioorganic & Medicinal Chemistry|July 18, 2021
Design, synthesis and biological evaluation of 2-styryl-5-hydroxy-4-pyrone derivatives and analogues as multiple functional agents with the potential for the treatment of Alzheimer's diseaseChenxian Hu, Liu Jiang, Li Tang, et al.Bioorganic & Medicinal Chemistry|October 27, 2018
Resveratrol-maltol hybrids as multi-target-directed agents for Alzheimer's diseaseGang Cheng, Ping Xu, Minkui Zhang, et al.European Journal of Medicinal Chemistry|January 4, 2021
Identification of N-phenyl-3-methoxy-4-pyridinones as orally bioavailable H3 receptor antagonists and β-amyloid aggregation inhibitors for the treatment of Alzheimer's diseaseMinkui Zhang, Li Tang, Liu Jiang, et al.European Journal of Medicinal Chemistry|April 6, 2025
Discovery of novel tetrahydroquinoline derivatives as potent, selective, and orally Available AR antagonistsLeer Yuan, Jianing Liao, Yiyang Qin, et al.Biosensors & Bioelectronics|August 28, 2015
Discovery of a novel fluorescent probe for the sensitive detection of β-amyloid depositsWenming Ren, Mingming Xu, Steven H Liang, et al.Journal of Medicinal Chemistry|November 4, 2024
Identification of Oral Bioavailable Coumarin Derivatives as Potential AR Antagonists Targeting Prostate CancerJinbiao Liao, Jianing Liao, Minkui Zhang, et al.European Journal of Medicinal Chemistry|March 2, 2020
Novel androgen receptor antagonist identified by structure-based virtual screening, structural optimization, and biological evaluationQin Tang, Weitao Fu, Minkui Zhang, et al.ACS Central Science|May 1, 2023
Small-Molecule Inhibition of Androgen Receptor Dimerization as a Strategy against Prostate CancerWeitao Fu, Hao Yang, Chenxian Hu, et al.Journal of Medicinal Chemistry|November 23, 2021
Discovery of a Novel Androgen Receptor Antagonist Manifesting Evidence to Disrupt the Dimerization of the Ligand-Binding Domain via Attenuating the Hydrogen-Bonding Network Between the Two MonomersWeitao Fu, Minkui Zhang, Jianing Liao, et al.Pageof 1